The shares of Hims & Hers Health Inc (HIMS) have recorded the market capitalization of 3.46B

Hims & Hers Health Inc (NYSE:HIMS) shares traded 0.69% higher at $15.96 on Wall Street last session.

HIMS stock price is now -24.30% away from the 50-day moving average and 19.05% away from the 200-day moving average. The market capitalization of the company currently stands at $3.46B.

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

Sponsored

On May 22, 2024, Citigroup Downgraded its previous ‘Buy’ rating to ‘Neutral’ on the stock increasing its target price from $16 to quote $20, while ‘Jefferies’ rates the stock as ‘Hold’

In other news, Melissa Baird, Officer bought 16,649 shares of the company’s stock on Aug 07 ’24. The stock was bought for $267,050 at an average price of $16.04. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 07 ’24, Chief Operating Officer Baird Melissa sold 16,649 shares of the business’s stock. A total of $269,998 was realized by selling the stock at an average price of $16.22. This leaves the insider owning 585,800 shares of the company worth $9.35 million. A total of 29.78% of the company’s stock is owned by insiders.

During the past 12 months, Hims & Hers Health Inc has had a low of $5.65 and a high of $25.74. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 2.68, and a quick ratio of 2.30. The fifty day moving average price for HIMS is $21.01 and a two-hundred day moving average price translates $13.4549 for the stock.

The latest earnings results from Hims & Hers Health Inc (NYSE: HIMS) was released for 2024-06-30. The net profit margin was 1.70% and return on equity was 5.31% for HIMS. The company reported revenue of $315.65 million for the quarter, compared to $207.91 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 51.82 percent.

Related Posts